GLP1R and inflammatory bowel disease: Based on the fact that GLP-1 and GLP-2 improve the intestinal epithelial barrier integrity and regulate mucosal innate immunity, GLP-1, GLP-2, and related analogs have been suggested potential therapeutic options for IBD [58].